Fundraising
Corsera Health
Corsera Health Raises $80M Series A | Once-Yearly Cardiovascular RNAi
Cambridge, MAJanuary 10, 20261 min read
Total Raised
$80M
Latest Round
Series A
Employees
40+
Corsera Health Closes $80M Series A
Corsera Health, developing once-yearly RNAi treatments for cardiovascular diseases, has raised $80 million in Series A funding.
Key Highlights
- Novel once-yearly dosing approach
- Focus on cardiovascular diseases
- RNAi therapeutic platform
Company Overview
Corsera Health is developing RNA interference therapeutics that require only once-yearly dosing, potentially transforming treatment adherence for chronic cardiovascular conditions.
Company Info
Headquarters
Cambridge, MA
Team Size
40+
Last Round
$80M(Jan 2026)
Investors (2)
O
OrbiMedLeadLead Investor
Healthcare investment firm
S
SofinnovaInvestor
Life sciences investor
Share
Related Reports
Fundraising
Swap
Swap Raises $100M Series C | Unified Commerce Platform
Commerce operating system Swap secures $100 million Series C just six months after Series B.
SalesTools Research
Jan 10, 2026
0 min readβ’$100M
Fundraising
Rain
Rain Raises $250M Series C | Stablecoin Payment Infrastructure
Crypto infrastructure company Rain secures $250 million Series C led by ICONIQ for stablecoin payments.
SalesTools Research
Jan 9, 2026
0 min readβ’$250M
Fundraising
Cambium
Cambium Raises $100M Series B | Advanced Materials for Defense
Advanced materials company Cambium secures $100 million Series B led by 8VC for defense and aerospace applications.
SalesTools Research
Jan 9, 2026
0 min readβ’$100M
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free